Novartis CEO Vas Narasimhan says the pharmaceutical industry hopes to work constructively with the new Trump administration.
Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals ...
The roller-coaster ride for Novartis—as it uses every bit of its legal muscle to extend Entresto's market exclusivity—took ...
Bloomberg on MSN1d
Novartis CEO Says They Will Have to 'Tackle Rhetoric' in US HealthcareVas Narasimhan, Novartis CEO speaks with Francine Laqcua about the Trump administration and the future of pharmaceuticals on ...
Novartis sues HHS over rejection of a proposed 340B rebate model, arguing it enhances transparency and compliance while ...
A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' ...
Greece on Monday prosecuted a pair of protected witnesses in a long-running bribery probe involving Swiss pharmaceutical firm Novartis for alleged perjury, a justice source said.
The Federal Circuit has issued a precedential decision reversing a lower court’s decision that certain claims of Novartis’s ...
The Federal Circuit reversed a Delaware district court’s 2023 ruling axing a Novartis Pharmaceuticals Corp. patent covering ...
Speaking to CNBC-TV18 at the World Economic Forum in Davos, Narasimhan discussed the company's operations in India, where ...
The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...
Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking MSN Pharmaceuticals from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results